Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells

Molecular Cancer Research

Volumn 7, Issue 7, 2009, Pages 1013-1020

  Altenburg, Jeffrey D ^a   Siddiqui, Rafat A ^a,b  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CHEMOKINE RECEPTOR CXCR4; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; METHYL BETA CYCLODEXTRIN; OMEGA 3 FATTY ACID; STEARIC ACID;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIPID RAFT; METASTASIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BREAST NEOPLASMS; CAVEOLIN 1; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE MICRODOMAINS; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 67651160516     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0385     Document Type: Article

References (47)

1. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6.
2. Locati M, Murphy PM. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu Rev Med 1999;50: 425-40.
3. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
4. Kang H, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast 2005;14:360-7.
5. Zlotnik A. Chemokines and cancer. Int J Cancer 2006;119:2026-9.
6. Karnoub AE, Weinberg RA. Chemokine networks and breast cancer metastasis. Breast Dis 2006;26:75-85.
7. Harvey JR, Mellor P, Eldaly H, Lennard TW, Kirby JA, Ali S. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids? Clin Cancer Res 2007;13:1562-70.
8. Tamamura H, Hori A, Kanzak N, et al. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer. FEBS Lett 2003;550:79-83.
9. Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel R, Jiang W. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 2005;7:R402-10.
10. Chen Y, Stamatoyannopoulos G, Song CZ. Down-regulation of CXCR4 byinducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 2003;63:4801-4.
11. Darash-Yahana M, Pikarsky E, Abramovitch R, et al. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 2004;18:1240-2.
12. Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M, Yamamoto N. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 2006;60:273-6.
13. Fernandis AZ, Prasad A, Band H, Klosel R, Ganju RK. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004;23:157-67.
14. Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, et al. NF-κB promotes breast cancer cell migration and metastasis byin ducing the expression of the chemokine receptor CXCR4. J Biol Chem 2003;278:21631-8.
15. Wang J, He L, Combs CA, Roderiquez G, Norcross MA. Dimerization of CXCR4 in living malignant cells: control of cell migration bya synthetic peptide that reduces homologous CXCR4 interactions. Mol Cancer Ther 2006;5: 2474-83.
16. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana ANA, Moreno-Ortiz MC, Martinez AC, Mellado M. The chemokine SDF-1α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J 1999; 13:1699-710.
17. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand 1972;192:85-94.
18. Berg JP, Glattre E, Haldorsen T, et al. Longchain serum fattyacids and risk of thyroid cancer: a population-based case-control study in Norway. Cancer Cause Control 1994;5:433-9.
19. Connolly JM, Gilhooly EM, Rose DP. Effects of reduced dietarylinoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer 1999;35:44-9.
20. Noguchi M, Minami M, Yagasaki R, et al. Chemoprevention of DMBA-induced mammaryca rcinogenesis in rats by low-dose EPA and DHA. Br J Cancer 1997;75:348-53.
21. Rose DP, Connolly JM. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int J Oncol 1999;15:1011-5.
22. Wu M, Harvey KA, Ruzmetov N, et al. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer 2005;117:340-8.
23. Shaikh SR, Dumaual AC, Castillo A, et al. Oleic and docosahexaenoic acid differentiallypha se separate from lipid raft molecules: a comparative NMR, DSC, AFM, and detergent extraction study. Biophys J 2004;87:1752-66.
24. Li Q, Zhang Q, Wang M, et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys 2007;466:250-9.
25. Li Q, Zhang Q, Wang M, et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007;89:169-77.
26. Siddiqui RA, Harvey KA, Zaloga GP, Stillwell W. Modulation of lipid rafts by ω-3 fattyacids in inflammation and cancer: implications for use of lipids during nutrition support. Nutr Clin Pract 2007;22:74-88.
27. Cabioglu N, Yazici MS, Arun B, et al. CCR7 and CXCR4 as novel biomarkers predicting axillaryly mph node metastasis in T1 breast cancer. Clin Cancer Res 2005;11:5686-93.
28. Kakinuma T, Hwang ST. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 2006;79:639-51.
29. Schley PD, Brindley DN, Field CJ. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 2007;137:548-53.
30. Li Q, Wang M, Tan L, et al. Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res 2005;46: 1904-13.
31. Kilsdonk EPC, Yancey PG, Stoudt GW, et al. Cellular cholesterol efflux mediated bycy clodextrins. J Biol Chem 1995;270:17250-6.
32. Neufeld EB, Cooney AM, Pitha J, et al. Intracellular trafficking of cholesterol monitored with a cyclodextrin. J Biol Chem 1996;271:21604-13.
33. Yancey PG, Rodrigueza WV, Kilsdonk EPC, et al. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J Biol Chem 1996;271:16026-34.
34. Anderson RGW. The caveolae membrane system. Annu Rev Biochem 1998; 67:199-225.
35. Smart EJ, Graf GA, McNiven MA, et al. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999;19:7289-304.
36. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997; 272:6525-33.
37. Loetscher M, Geiser T, O'Reilly T , Zwahlen R, Baggiolini M, Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly-expressed in leukocytes. J Biol Chem 1994;269:232-7.
38. Halliwell B. Albumin - an important extracellular antioxidant? Biochem Pharmacol 1988;37:569-71.
39. Fermor BF, Masters JR, Wood CB, Miller J, Apostolov K, Habib NA. Fatty acid composition of normal and malignant cells and cytotoxicity of stearic, oleic and sterculic acids in vitro. Eur J Cancer 1992;28A:1143-7.
40. Jones R, Nelson M. The role of receptors in the HIV-1 entryprocess. Eur J Med Res 2007;12:391-6.
41. Singh S, Sadanandam A, Singh RK. Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev 2007;26:453-67.
42. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007;97:714-21.
43. Mines M, Ding Y, Fan GH. The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr Med Chem 2007;14:2456-70.
44. van Greevenbroek MM, Voorhout WF, Erkelens DW, van Meer G, de Bruin TW. Palmitic acid and linoleic acid metabolism in Caco-2 cells: different triglyceride synthesis and lipoprotein secretion. J Lipid Res 1995; 36:13-24.
45. English D, Kovala AT, Welch Z, et al. Induction of endothelial cell chemotaxis bysphingosine 1-phosphate and stabilization of endothelial monolayer barrier function byly sophosphatidic acid, potential mediators of hematopoietic angiogenesis. J Hematother Stem Cell Res 1999;8:627-34.
46. Boguslawski G, Grogg JR, Harvey KA, English D. Use of DAPI staining for quantitation of cell chemotaxis. Biotechniques 2001;30:42-4.
47. Wessel D, Flügge UI. A method for the quantitative recoveryof protein in dilute solution in the presence of detergents and lipids. Anal Biochem 1984; 138:141-3.